Willow vs Wellmedr: Progress Tracking vs Low Starting Prices

Quick verdict: Willow focuses on a structured telehealth-first oral GLP-1 weight management program with progress tracking and follow-up support, while WellMedr emphasizes lower starting prices and pricing guarantees for compounded GLP-1 plans.

Explore Willow’s program and tracking tools

How Willow vs Wellmedr differ at a glance

This direct comparison highlights the most distinctive differences between Willow and WellMedr: treatment model and support, starting price and pricing structure, shipping and review speed, and regulatory notes on compounded medications. Both require clinician approval before treatment.

Treatment model and support

Willow positions its offering as an oral GLP-1 weight management program delivered via a telehealth-first workflow with licensed telehealth teams, progress tracking tools, and follow-up consultations designed to translate medication effects into longer-term behavior change. WellMedr offers GLP-1 plans that advertise lifetime locked-in pricing, no dose-based price increases, and same-day review plus free overnight shipping, with plan marketing that includes money-back and delivery guarantees.

Price and plan structure

Willow’s captured starting price is 299. WellMedr presents GLP-1 plans starting at $89/month and notes semaglutide plans starting at $49 a month and tirzepatide from $89 a month. WellMedr markets lifetime locked-in pricing and no dose-based price increases as plan features; Willow’s evidence mentions higher monthly entry pricing for some plans as a con.

See WellMedr’s starting plans and pricing

Five-criteria comparison table

Criteria	Willow	WellMedr
Primary approach	Telehealth-first program with progress tracking and follow-up consultations	Online GLP-1 plans with fast review and shipping
Starting price	Starting price: 299	Starting at $89/month; semaglutide noted from $49/month
Pricing guarantees	Not advertised; higher monthly entry pricing noted for some plans	Lifetime locked-in pricing and no dose-based price increases (advertised)
Fulfillment speed	Follow-up and progress tracking emphasized; shipping details not captured	Same-day review and free overnight shipping advertised
Regulatory note	Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality	Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality

Support, follow-up, and user experience

Willow emphasizes progress tracking tools and follow-up consultations as part of a structured weight management journey, positioning the program for users who want behavioral scaffolding alongside medication. WellMedr emphasizes plan features like on-time refills and delivery guarantees in its captured landing-page evidence, and highlights dose guidance and advertising claims about clinical research without tying outcomes specifically to WellMedr.

Learn about Willow’s follow-up consultations

Safety and regulatory considerations

Both sources include regulatory notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. WellMedr’s captured evidence also includes safety language about potential GLP-1 medication risks such as thyroid C-cell tumors and advises seeking care for specific symptoms. Both require treatment to be available only when a licensed clinician determines it is medically appropriate.

Final take on Willow vs Wellmedr

If you prioritize a structured telehealth program with progress tracking and clinician follow-up, Willow focuses on that model; if you prioritize lower advertised starting prices, lifetime locked-in pricing and fast shipping claims, WellMedr emphasizes those features. Both require clinician approval and note that compounded medications are not FDA-reviewed.

Compare WellMedr plans and terms

Choose based on this comparison

• Choose Willow if you want a telehealth-first oral GLP-1 program that emphasizes progress tracking and follow-up consultations.
• Choose WellMedr if you want GLP-1 plans advertised with lower starting prices, lifetime locked-in pricing, and same-day review plus overnight shipping claims.

Willow vs Wellmedr: use the distinctions above to match the program features and pricing structure to your priorities, keeping in mind clinician approval requirements and the regulatory notes on compounded medications.